Skip to main content
HANGZHOU ALLTEST BIOTECH CO.,LTD. logo

HANGZHOU ALLTEST BIOTECH CO.,LTD. — Investor Relations & Filings

Ticker · 688606 ISIN · CNE1000053G6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 626 across all filing types
Latest filing 2026-05-17 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688606

About HANGZHOU ALLTEST BIOTECH CO.,LTD.

https://www.alltests.com.cn/

Hangzhou AllTest Biotech Co., Ltd. specializes in the research, development, and manufacturing of advanced in vitro diagnostic (IVD) solutions. The company offers a comprehensive portfolio of rapid diagnostic test kits utilizing lateral flow immunoassay technology. Key product categories include infectious disease diagnostics, drug of abuse testing, oncology and cardiac markers, fertility tests, and veterinary diagnostics. AllTest Biotech focuses on providing high-quality, reliable, and easy-to-use testing solutions for clinical laboratories, hospitals, and point-of-care settings globally. The organization maintains rigorous quality management systems, holding international certifications such as ISO 13485, with many products receiving CE marking and FDA clearance. By leveraging innovative R&D and large-scale production capabilities, the company delivers cost-effective diagnostic tools designed to improve healthcare outcomes through early detection and monitoring.

Recent filings

Filing Released Lang Actions
关于上海证券交易所对公司2025年年度报告信息披露监管问询函的回复公告
Regulatory Filings Classification · 85% confidence The document is a company announcement providing its formal reply to a Shanghai Stock Exchange regulatory inquiry letter regarding the disclosure of its 2025 annual report. It is not the annual report itself but a regulatory response, fitting the ‘Regulatory Filings (RNS)’ category as a compliance filing.
2026-05-17 Chinese
致同会计师事务所（特殊普通合伙）关于对杭州奥泰生物技术股份有限公司的2025年年报问询函审计相关事项的专项说明
Audit Report / Information Classification · 85% confidence The document is a ‘‘专项说明’’ (special explanation) prepared by Grant Thornton in response to a regulatory inquiry letter from the Shanghai Stock Exchange about audit‐related questions on the company’s 2025 annual report. It is not the full annual report itself or merely an announcement; rather, it provides audit‐related information and analyses in standalone form. This matches the definition of an Audit Report / Information filing (Code: AR).
2026-05-17 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a formal resolution announcement (“股东会决议公告”) of the annual shareholders’ meeting, listing proposals considered and detailed vote counts and percentages. This matches the “Declaration of Voting Results & Voting Rights Announcements” category, which covers official vote results at an AGM or EGM.
2026-05-12 Chinese
礼丰律师事务所关于杭州奥泰生物技术股份有限公司2025年年度股东会的法律意见书
Regulatory Filings Classification · 15% confidence The document is a law firm’s legal opinion letter (法律意见书) concerning the legality of the company’s 2025 annual shareholders’ meeting procedures and voting results. It does not constitute the meeting materials themselves (AGM materials), nor is it a declaration of results issued by the company, but rather a legal attestation. There is no specific category for legal opinion letters, so it falls under the fallback category of Regulatory Filings (RNS).
2026-05-12 Chinese
关于以集中竞价交易方式回购公司股份比例达到 2%暨回购进展公告
Regulatory Filings
2026-05-08 Chinese
2025年年度股东会会议资料
AGM Information Classification · 95% confidence The document is titled "2025年年度股东会会议资料" which translates to "2025 Annual General Meeting (AGM) Meeting Materials". It contains detailed information about the agenda, meeting rules, voting procedures, and multiple proposals to be discussed and voted on during the 2025 AGM. The content includes reports such as the 2025 Board of Directors Work Report, the 2025 Annual Report and its summary, profit distribution plans, remuneration plans, and audit firm reappointment proposals. The document is clearly a set of materials prepared for the Annual General Meeting, intended to inform shareholders about the meeting's agenda and proposals. It is not the Annual Report itself, nor an announcement of a report publication, but the meeting materials for the AGM. Therefore, the correct classification is AGM Information (AGM-R). The document length is substantial (15,000 characters), and it is not a brief announcement or certification, so it does not fall under RPA or RNS. Confidence is high due to explicit references to AGM meeting materials and agenda.
2026-04-27 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.